SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-25
👔
Fortress Biotech, Inc.
@FBIO_InsiderForm 4 Filing: Jin David Acquires (Grant) shares of $FBIO
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
Fortress Biotech, Inc.
Ticker: $FBIO
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-22
Shares: 400,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Jin David, holds the title of Chief Financial Officer at Fortress Biotech, Inc..
On 2026-06-22, the insider transacted 400,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Jin David (Chief Financial Officer) was granted $0 of $FBIO
Post-Transaction Position: 1,651,571 shares
SEC Accession No: 0001930732-26-000003 (CIK: 1930732)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.